Lincoln Pharmaceuticals Ltd reports 23% rise in the Standalone Net Profit at Rs.14.99 crore in Q1FY21
Financial Highlights (Standalone) (Amount in Cr except EPS) Q1 FY21 Q1 FY20 Y-O-Y FY20 Net Revenue 103.01 96.17 7.11% 388.22 EBITDA 22.42 19.04 17.74% 71.50 Profit before Tax 20.67 17.00…